Search

everythinglearnresearchcommunity

for

Search:↓

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

Low iron and vitamin D levels are linked to hair loss in women.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Healthy women tend to lose more hair in July and April, and the least in February.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Low iron levels are linked to more hair loss in non-menopausal women.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Lupus can cause hair loss and nail changes, with treatments available for both.

Environmental and cosmetic factors, including heat, chemicals, and sun exposure, can cause hair loss and damage.

Careful management of blood thinners is crucial for lupus patients with APS.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.